Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000919574-25-003574
Filing Date
2025-06-12
Accepted
2025-06-12 21:10:05
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 13328
2 d11825519_ex99-a.htm EX-99 7841
3 d11825519_ex99-b.htm EX-99 2587
  Complete submission text file 0000919574-25-003574.txt   25728
Mailing Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021
Business Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021 4254011400
BIOLIFE SOLUTIONS INC (Subject) CIK: 0000834365 (see all company filings)

EIN.: 943076866 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-40587 | Film No.: 251044571
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 1350 AVENUE OF THE AMERICAS SUITE 2600 NEW YORK NY 10019
Business Address 1350 AVENUE OF THE AMERICAS SUITE 2600 NEW YORK NY 10019 212.300.5575
Casdin Capital, LLC (Filed by) CIK: 0001534261 (see all company filings)

EIN.: 800752351 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A